What a dream weekend it would have been if we would have read an announcement that next week MRS is releasing CellLive and ordered a quantity of 100 research systems to get production into gear, paid full in advance, with an parallel order of 30 neurosurgery systems from Carl Zeiss to cover their initial customer demand!
Expecting the sort of above announcement certainly delivered disappointment and like kids not getting their lolly many got a fit and sold their shares.
The fact is we were never in a better position before. We longtime oilers are used to half yearly or yearly progress delays stretching 15 years!
Now we are down to 3 months product release delay in a position of no company debt on the balance sheet and intensified infrastructure!!!
Big deal!!!
"The intensified infrastructure will help in moving the Company's two priority projects to completion this calender year, being MRS research imaging and Zeiss neurosurgery imaging."
It's time to buy your shares now, because the end of the calender year is not so far away and then you pay 25 cents per share!
Heads up, read the good news between the lines, just a bit more patience!
wink99
Add to My Watchlist
What is My Watchlist?
